NCT00532727View on ClinicalTrials.gov

Triple Negative Breast Cancer Trial

PHASE3UnknownINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2020

Conditions
Breast Cancer
Interventions
DRUG

Carboplatin

AUC 6 every 3 weeks for six cycles (18 weeks)

DRUG

Docetaxel

100mg/m2 every 3 weeks for six cycles (18 weeks)

Trial Locations (1)

SE1 9RT

Guy's and St Thomas' Hospital NHS Foundation Trust, London

Sponsors

Collaborators (1)

Cancer Research UK
All Listed Sponsors
collaborator

King's College London

OTHER

collaborator

Cancer Research UK

OTHER

collaborator

Breakthrough Breast Cancer

OTHER

lead

Institute of Cancer Research, United Kingdom

OTHER